Your Health, We Care
Release date: 2024-07-10 14:39:59 Recommended: 137
Lorlatinib is used as a first-line treatment for patients with anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC). In the critical phase III CROWN study, for ALK positive NSCLC patients who had not received prior treatment, loratinib reduced the risk of disease progression or death by 72% compared to the clotozantinib group.
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of L···【more】
Recommended：354Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appoint···【more】
Recommended：363Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensi···【more】
Recommended：423Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in t···【more】
Recommended：284Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has ···【more】
Recommended：477Release date: 2024-07-09
From the Black Sea, the most terrifying ocean on earth, to the Mediterranean Sea···【more】
Recommended：295Release date: 2024-07-09
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently mad···【more】
Recommended：462Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest incr···【more】
Recommended：367Release date: 2024-07-09
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the r···【more】
Recommended：67Release date: 2025-12-17
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved nirap···【more】
Recommended：60Release date: 2025-12-15
The U.S. Food and Drug Administration (FDA) announced today that it has approved···【more】
Recommended：79Release date: 2025-12-10
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisoca···【more】
Recommended：74Release date: 2025-12-08
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full ap···【more】
Recommended：94Release date: 2025-12-04
Primary analysis data from the randomized, double-blind, placebo-controlled phas···【more】
Recommended：90Release date: 2025-12-01
